Abstract
The anti-inflammatory activities of glucocorticoids are supposed to be based on two distinct mechanisms: 1. the downregulation of mediator synthesis, e.g. of the cytokines Il-1, Il-2 Il-4, Il-6, Il-8, tumor necrosis factor-α granulocyte-macrophage colony-stimulating factor and interferon-γ [1,2]; 2. the production of anti-inflammatory proteins, e.g. the lipocortins and vasocortins [3]. Stimulation of peripheral monocytes with glucocorticoid (prednylidene) is followed by the generation of a macrophage subtype which is defined by the expression of the surface antigen RM3/1. In vivo this subtype is associated with the down regulation of the inflammatory process [4,5]. In vitro these cells secrete anti-inflammatory activity.The increasing proportion of RM3/1
macrophages during the first 12–24 h in the presence of prednylidene in culture medium [5] was accompanied by the some proinflammatory activity followed by anti-inflammatory activity from 10 h onwards (Fig.1). The formation of this activity continued when the glucocorticoid was removed from the medium after 40 h. The anti-inflammatory activity showed a dose dependency as is demonstrated in Fig. 2. In this experiment the doses of the protein extract corresponded to the number of macrophages which had produced them (cell equivalents). To make the unitage of the protein extracts independent of varying functions of the cells the anti-inflammatory activity was rather related to the effect of dexamethasone (dexa equivalents).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schleimer RP. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993; 45 (Suppl l): 3–7
Barnes PJ, Adcock I. Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 1993; 14: 436–441
Sautebin L, Carnuccio R, Ialenti A, DiRosa M. Lipocortin and vasocortin: two species of anti-in- flammatory proteins mimicking the effects of glucocorticoids. Pharmacol Res 1992; 25: 1–12
Zwadlo G, Voegeli A, Schulze Osthoff K, Sorg C. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down-regulation phase of the inflammatory process. Exp Cell Biol 1987; 55: 295–304
Zwadlo-Klarwasser G, Bent S, Haubeck HD, Sorg C, Schmutzler W. Glucocorticoid-induced ap¬pearance of the macrophage subtype RM3/1 in peripheral blood of man. Int Arch Allergy Appi Immunol 1990; 91: 175–180
Hamann W, Flöter A, Schmutzler W, Zwadlo-Klarwasser G. Characterization of a novel anti-in- flammatory protein generated by RM3/1 macrophages derived from glucocorticoid treated human monocytes. Inflamm Res 1995; 44: 535–540
Flower RJ. Lipocortin and the mechanism of action of the glucocorticoids. Br J Pharmacol 1988; 94: 987–1015
Oyanagui Y, Suzuki S. Vasoregulin, a glucocorticoid-inducible vascular permeability inhibitory protein. Agents Actions 1985; 17: 270–277
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hamann, W., Flöter, A., Zwadlo-Klarwasser, G., Schmutzler, W. (1997). Generation of Anti-inflammatory Protein in Glucocorticoid-lnduced Human RM3/1 Macrophages. In: Ring, J., Behrendt, H., Vieluf, D. (eds) New Trends in Allergy IV. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60419-5_25
Download citation
DOI: https://doi.org/10.1007/978-3-642-60419-5_25
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64398-9
Online ISBN: 978-3-642-60419-5
eBook Packages: Springer Book Archive